1. Home
  2. SRPT vs PRA Comparison

SRPT vs PRA Comparison

Compare SRPT & PRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • PRA
  • Stock Information
  • Founded
  • SRPT 1980
  • PRA 1976
  • Country
  • SRPT United States
  • PRA United States
  • Employees
  • SRPT N/A
  • PRA N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • PRA Property-Casualty Insurers
  • Sector
  • SRPT Health Care
  • PRA Finance
  • Exchange
  • SRPT Nasdaq
  • PRA Nasdaq
  • Market Cap
  • SRPT 1.9B
  • PRA 1.2B
  • IPO Year
  • SRPT 1997
  • PRA N/A
  • Fundamental
  • Price
  • SRPT $23.20
  • PRA $23.97
  • Analyst Decision
  • SRPT Hold
  • PRA Hold
  • Analyst Count
  • SRPT 30
  • PRA 4
  • Target Price
  • SRPT $36.56
  • PRA $21.00
  • AVG Volume (30 Days)
  • SRPT 5.3M
  • PRA 420.0K
  • Earning Date
  • SRPT 11-03-2025
  • PRA 11-05-2025
  • Dividend Yield
  • SRPT N/A
  • PRA N/A
  • EPS Growth
  • SRPT N/A
  • PRA N/A
  • EPS
  • SRPT N/A
  • PRA 0.95
  • Revenue
  • SRPT $2,481,531,000.00
  • PRA $1,128,928,000.00
  • Revenue This Year
  • SRPT $9.68
  • PRA N/A
  • Revenue Next Year
  • SRPT N/A
  • PRA N/A
  • P/E Ratio
  • SRPT N/A
  • PRA $25.39
  • Revenue Growth
  • SRPT 64.89
  • PRA N/A
  • 52 Week Low
  • SRPT $10.42
  • PRA $13.00
  • 52 Week High
  • SRPT $138.81
  • PRA $24.22
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 56.64
  • PRA 45.71
  • Support Level
  • SRPT $21.29
  • PRA $24.05
  • Resistance Level
  • SRPT $24.38
  • PRA $24.17
  • Average True Range (ATR)
  • SRPT 1.05
  • PRA 0.09
  • MACD
  • SRPT -0.05
  • PRA -0.01
  • Stochastic Oscillator
  • SRPT 66.02
  • PRA 25.93

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About PRA ProAssurance Corporation

ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.

Share on Social Networks: